RECI Real Estate Credit Investments

Q&A on Real Estate Credit Investments: Understanding the discount, its rise, and future prospects

Hardman & Co Research
Q&A on Real Estate Credit Investments: Understanding the discount, its rise, and future prospects

01-Nov-2024 / 12:00 GMT/BST
The issuer is solely responsible for the content of this announcement.

Hardman & Co analyst interview | Diversified Financial Services

Q&A on Real Estate Credit Investments (RECI) | Understanding the discount, its rise, and future prospects

Real Estate Credit Investments (RECI) Plc is the topic of conversation when Hardman & Co analyst Mark Thomas joins DirectorsTalk Interviews.

In this interview, Mark provides insights into Real Estate Credit Investments (RECI) plc, examining recent changes in the company’s discount rate and the factors driving its closure. The discussion addresses the strategies implemented by RECI’s management, including portfolio adjustments and capital allocation measures, which have contributed to a more resilient positioning amidst evolving market conditions. Mark also shares perspectives on market dynamics that have favoured RECI, the outlook for its continued performance, and potential risks ahead.

RECI is a specialist investor focused on European real estate credit markets, prioritising fundamental credit and value in its investment strategy.

Listen to the interview

 

If you are interested in meeting the company, you can register your interest

To contact us:

Hardman & Co
9 Bonhill Street

London

EC2A 4DJ

 

Follow us on X: 

Analysts:

Mark Thomas

Mike Foster



 

 



 

Hardman & Co Research can be accessed for free under MiFID. Please to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
End of Announcement - EQS News Service

2021115  01-Nov-2024 

fncls.ssp?fn=show_t_gif&application_id=2021115&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
01/11/2024

Underlying

RECIReal Estate Credit Investments

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Real Estate Credit Investments

Mark Thomas ... (+2)
  • Mark Thomas
  • Mike Foster
RECI Real Estate Cre...

Real Estate Credit Investments (RECI): The rise of private credit: thr...

One of the key trends in global financing markets has been the rise of private credit. In this report, we consider the implications for RECI. On the upside, we note i) the disintermediation of banks reconfirms the drivers to its business model, ii) this should be positive for sentiment, and iii) most of RECI’s competitive advantages relative to banks also apply to private credit funds. On the downside, we note i) competition will increase, especially for higher-end loans and staff, although RECI...

RECI REAL ESTATE CREDIT INVESTMENTS
02/20/25 February 20, 2025 1 EN
 PRESS RELEASE
Free
RECI Real Estate Cre...

Hardman & Co publication on Real Estate Credit Investments (RECI) - Th...

Hardman & Co Research Hardman & Co publication on Real Estate Credit Investments (RECI) - The rise of private credit: threats and opportunities 20-Feb-2025 / 12:30 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman & Co Research on Real Estate Credit Investments (RECI): The rise of private credit: threats and opportunities  One of the key trends in global financing markets has been the rise of private credit. In this report, we consider the implications for RECI. On the upside, we note i) the disintermediation of banks reconfirms the drivers...

February 20, 2025 1 EN
Keith Hiscock ... (+2)
  • Keith Hiscock
  • Mark Thomas
ARBB Arbuthnot Banki...
RECI Real Estate Cre... ... (+8)

Hardman & Co Monthly: February 2025

Feature article: The October 2024 Budget - We got it wrong By Keith Hiscock, CEO at Hardman & Co In this month's feature article, we review the effects of the 2024 Budget and consider what might happen in the coming months. Our Hardman Monthly of October 2024 looked forward to the first Labour Budget for 14 years. The main theme was that, because the new Chancellor, Rachel Reeves, had ruled out increases in taxes on ‘working people’, investors would bear the brunt of any tax increases to fill ...

ARBB ARBUTHNOT BANKING GROUP
RECI REAL ESTATE CREDIT INVESTMENTS
ACSO ACCESSO TECHNOLOGY GROUP
VTAS VOLTA FINANCE (GBP)
HAT H&T GROUP
APAX APAX GLOBAL ALPHA
ICGT ICG ENTERPRISE TRUST
A0MXLB NB PRIVATE EQUITY PARTNERS
02/03/25 February 3, 2025 1 EN
Brian Moretta ... (+3)
  • Brian Moretta
  • Mark Thomas
  • Martin Hall
SN. SMITH & NEPHEW ...
AGL ANGLE PLC ... (+62)

Hardman & Co Monthly: January 2025

Feature article: Hardman & Co Healthcare Index, 2024 – Tough year for Life Sciences By Dr Martin Hall The main function of the HHI is to monitor the performance, and to highlight the attractiveness, of life sciences investments over the long term, and to try to identify those stocks that have disruptive technologies that consistently allow them to outperform both the index and the markets. Many of the 53 constituents of the index are high-risk, with micro-capitalisations and a long way from pro...

SN. SMITH & NEPHEW PLC
AGL ANGLE PLC
DEMG DELTEX MEDICAL GROUP PLC
TSTL TRISTEL PLC
TRX TISSUE REGENIX GROUP
EKF EKF DIAGNOSTICS HOLDINGS
ODX OMEGA DIAGNOSTICS
AVCT AVACTA GROUP
PHP PRIMARY HEALTH PROPERTIES PLC
AGY ALLERGY THERAPEUTICS PLC
ARBB ARBUTHNOT BANKING GROUP
APH ALLIANCE PHARMA PLC
FUM FUTURA MEDICAL PLC
ALNOV NOVACYT SAS
VLG VENTURE LIFE GROUP
RECI REAL ESTATE CREDIT INVESTMENTS
IMM IMMUPHARMA
PRM PROTEOME SCIENCES PLC
ACSO ACCESSO TECHNOLOGY GROUP
GNS GENUS PLC
SUN SURGICAL INNOVATIONS GROUP PLC
AMS ADVANCED MEDICAL SOLUTIONS GROUP PLC
OMG OXFORD METRICS
EAH ECO ANIMAL HEALTH GROUP
JDG JUDGES SCIENTIFIC
VTAS VOLTA FINANCE (GBP)
SDI SDI GROUP
HVO HVIVO
INDV INDIVIOR PLC
VAL VALIRX
FARON FARON PHARMACEUTICALS OY
ONC ONCIMMUNE HOLDINGS
STX SHIELD THERAPEUTICS
CSN CHESNARA PLC
SNG SYNAIRGEN PLC
IPO IP GROUP
HAT H&T GROUP
SCLP SCANCELL HOLDINGS
SYNC SYNCONA
CIR CIRCASSIA GROUP
SPI SPIRE HEALTHCARE GROUP PLC
AGR ASSURA PLC
APAX APAX GLOBAL ALPHA
ICGT ICG ENTERPRISE TRUST
GDR GENEDRIVE
CTEC CONVATEC GROUP PLC
CREO CREO MEDICAL GROUP
SBTX SKINBIOTHERAPEUTICS
A0MXLB NB PRIVATE EQUITY PARTNERS
FAB FUSION ANTIBODIES
IXI IXICO
OXB OXFORD BIOMEDICA PLC
ABDX ABINGDON HEALTH
IMCR IMMUNOCORE HOLDINGS ADS
POLX POLAREAN IMAGING
AREC ARECOR THERAPEUTICS
ONT OXFORD NANOPORE TECHNOLOGIES PLC
SLN SILENCE THERAPEUTICS PLC
SAR SAREUM HOLDINGS PLC
BAI BENEVOLENTAI
4BB 4BASEBIO PLC
TISSUE REGENIX GROUP PLC
01/10/25 January 10, 2025 1 EN
 PRESS RELEASE
Free
RECI Real Estate Cre...

Q&A on Real Estate Credit Investments: Understanding the discount, its...

Hardman & Co Research Q&A on Real Estate Credit Investments: Understanding the discount, its rise, and future prospects 01-Nov-2024 / 12:00 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman & Co analyst interview | Diversified Financial Services Q&A on Real Estate Credit Investments (RECI) | Understanding the discount, its rise, and future prospects Real Estate Credit Investments (RECI) Plc is the topic of conversation when Hardman & Co analyst Mark Thomas joins DirectorsTalk Interviews. In this interview, Mark provides insights into Real E...

November 1, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch